Liaoning Chengda Biotechnology (688739.SH) signed a strategic cooperation agreement with the Institute of Microbiology of the Chinese Academy of Sciences.

Liaoning Chengda Biotechnology (688739.SH) announced that the company has recently signed a "Strategic Cooperation Agreement" with the Institute of Microbiology of the Chinese Academy of Sciences (referred to as "Microbiology Institute"). The two parties will focus on the field of emerging and infectious diseases, with a key focus on the prevention of vector-borne infectious diseases. They will jointly apply for national and provincial-level scientific research projects, and work together to address infectious disease prevention and control. This agreement falls under the category of cooperative intentions and will not have a direct impact on the company's performance in 2025 and beyond. The specific impact on the company's performance will depend on the progress and implementation of specific projects in the future.